INFRASTRUCTURAL CAPABILITY OF INVESTIGATOR-INITIATED TRIALS INVOLVING UNAPPROVED INVESTIGATIONAL DRUGS IN JAPAN

被引：0
|
作者：
Shimizu, T. [1 ]
Kaneda, H. [1 ]
Tsurutani, J. [1 ]
Okamoto, K. [1 ]
Tanaka, K. [1 ]
Ohnishi, R. [1 ]
Nomura, M. [1 ]
Aida, H.
Hashii, C.
Nakagawa, K. [1 ]
机构：
[1] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt452.2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Transparency and accuracy in funding investigator-initiated clinical trials: a systematic search in clinical trials databases
    Madeira, Catarina
    Santos, Francisco
    Kubiak, Christine
    Demotes, Jacques
    Monteiro, Emilia Carreira
    BMJ OPEN, 2019, 9 (05):
  • [42] Investigator-initiated pragmatic trials in developing countries - much needed but much ignored
    Shafiq, Nusrat
    Pandhi, Promila
    Malhotra, Samir
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (01) : 141 - 142
  • [43] Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer
    Tsai, Susan
    Evans, Douglas B.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (01) : 69 - 74
  • [44] Protocol performance metrics and resource utilization of phase II investigator-initiated trials
    Durivage, H.
    Bridges, K. D.
    Sauers, J.
    Wellons, M.
    Baker, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group
    Kim, Bum Jun
    Maeng, Chi Hoon
    Keam, Bhumsuk
    Im, Young-Hyuck
    Ro, Jungsil
    Jung, Kyung Hae
    Im, Seock-Ah
    Kim, Tae Won
    Lee, Jae Lyun
    Heo, Dae Seog
    Kim, Sang-We
    Park, Keunchil
    Ahn, Myung-Ju
    Cho, Byoung Chul
    Kim, Hoon-Kyo
    Kang, Yoon-Koo
    Cho, Jae Yong
    Yun, Hwan Jung
    Nam, Byung-Ho
    Zang, Dae Young
    CANCER RESEARCH AND TREATMENT, 2025, 57 (01): : 39 - 46
  • [46] Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN)
    Madeira, C.
    Pais, A.
    Kubiak, C.
    Demotes, J.
    Monteiro, E. C.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2016, 4 : 141 - 148
  • [47] Ohio CTSAs Implement a Reliant IRB Model for Investigator-Initiated Multicenter Clinical Trials
    Cola, Philip A.
    Reider, Carson
    Strassor, Jane E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2013, 6 (03): : 176 - 178
  • [48] Investigator-initiated Randomized Controlled Trials in Infectious Diseases: Better Value for Money for Registration Trials of New Antimicrobials
    Paul, Mical
    Harbarth, Stephan
    Huttner, Angela
    Thwaites, Guy E.
    Theuretzbacher, Ursula
    Bonten, Marc J. M.
    Leibovici, Leonard
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (07) : 1259 - 1264
  • [49] CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASE
    Krishnasamy, Rathika
    Robison, Laura
    Howell, Martin
    Howard, Kirsten
    Reidlinger, Donna
    Shenoy, Aparna
    Mallard, Alistair
    Pascoe, Elaine
    Cho, Yeoungjee
    Viecelli, Andrea
    Roberts, Matthew
    Toussaint, Nigel
    Badve, Sunil
    Peh, Chen Au
    Irish, Ashley
    Johnson, Davidw
    Hawley, Carmel M.
    NEPHROLOGY, 2022, 27 : 43 - 44
  • [50] Navigating investigator-initiated clinical trials: A call for guidelines & monitoring frameworks from an Indian context
    Kumar, Gunjan
    Cherian, Jerin Jose
    Mathur, Roli
    Mukherjee, Aparna
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2024, 160 (02) : 141 - 149
12345